Bright Minds Biosciences (DRUG) Stock Research

Bright Minds Biosciences

· DRUG

Dashboard

Financials

Ratios

Valuation

Statistics

490.638 M

+0.16%

Monday

Bright Minds initiated with bullish view at LifeSci Capital

DRUG

Sep 28, 6:27 AM

Over a week ago

Psychedelic: Enveric, Helus, Bright Minds report earnings results

Aug 20, 11:27 AM

One new option listing on July 7th

DRUG

Jul 7, 8:30 AM

Psychedelic: Enveric, NRx, Bright Minds report quarterly earnings

May 21, 11:26 AM

Bright Minds price target raised by $30 at Piper Sandler, here's why

DRUG

May 20, 6:44 AM

Psychedelic: Clearmind's CMND-100 meets primary endpoint in trial

Apr 16, 11:20 AM

Bright Minds initiated with bullish view at Jefferies, here's why

DRUG

Apr 12, 7:16 PM

Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results

Mar 5, 10:14 AM

Bright Minds price target raised by $30 at H.C. Wainwright, here's why

DRUG

Mar 4, 8:31 AM

Bright Minds price target lowered by $16 at Baird, here's why

DRUG

Feb 13, 9:15 AM

Psychedelic: Bright Minds reports results from Phase 2 BMB-101 trial

Jan 8, 10:57 AM

Bright Minds 1.945M share Secondary priced at $90.00

DRUG

Jan 8, 6:25 AM

Bright Minds price target raised by $60 at Baird, here's why

DRUG

Jan 7, 7:56 AM

Bright Minds price target raised by $75 at BTIG, here's why

DRUG

Jan 7, 6:42 AM

Bright Minds announces $100M common shares offering

DRUG

Jan 6, 4:06 PM

Bright Minds announces results from Phase 2 BREAKTHROUGH trial of BMB-101

DRUG

Jan 6, 7:22 AM

Bright Minds price target raised by $7 at Baird, here's why

DRUG

Nov 7, 7:23 AM

Psychedelic: Compass Pathways, GH Research report Q3 earnings

Nov 6, 11:33 AM

No more stories

Charts